Venture Life seeks consumer healthcare brands
22 January 2021
Self-care group Venture Life is keen to acquire consumer healthcare brands following its recent funding round, according to chief executive officer Jerry Randall.
Industry News - Tag: Venture Life
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
Industry in brief | Viatris, Venture Life
20 November 2020
Mylan and Pfizer’s Upjohn business have now been combined into Viatris, and Venture Life has raised additional funds.
Industry in brief | Jacobson, Nature’s Bounty, Dentyl
2 October 2020
Jacobson Pharma plans to spin off its branded healthcare business, The Nature’s Bounty Co has joined the US Consumer Healthcare Products Association (CHPA) and Venture Life’s Dentyl mouthwash is participating in a COVID-19 trial.
Industry in brief | Alcon, Karo, Venture Life, AFT
21 July 2020
Alcon is extending its Pataday OTC range in the US, Karo Pharma and Venture Life have released financial results, while AFT Pharmaceuticals is working with RooLife Group to launch an online health and pharmacy store in China.
Industry in brief | Venture Life, Stada, Bayer
27 April 2020
Venture Life has signed an agreement with a Chinese partner, Stada has recruited from Google, and Bayer’s Supervisory Board has a new chairman following the departure of Werner Wenning after 54 years with the German company.
Venture Life grows in Europe with PharmaSource
Premium
27 December 2019
Self-care group Venture Life is expanding its presence in continental Europe by acquiring Netherlands-based PharmaSource in a deal worth up to EUR6.50 million (USD7.30 million).
Industry in brief | Nestlé, Nature's Sunshine, Venture Life
26 September 2019
Nestlé Health Science has taken a stake in Before Brands, Nature's Sunshine Products is entering the cannabidiol (CBD) market in the US, and Venture Life has released financial results.
Industry in brief | Probi, Karo, Venture Life, RB
19 July 2019
Probi and Karo Pharma have released financial results, Venture Life is pushing on with international expansion, and RB has agreed to pay up to USD1.4 billion to settle a US investigation.